Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-02-28

Clinical Trial Update: Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fluciclovine uptake in cervical, endometrial, and ovarian epithelial cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluciclovine (Fluciclovine)

Snippet

Sponsor: Bital Savir-Baruch | Conditions: Cervical Cancer, Endometrial Cancer | Phase 4 | Status: UNKNOWN